Sarmiento, Evelyn .

HRN: 26-95-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFUROXIME 750MG (VIAL)
11/20/2025
11/26/2025
IV
1.5g
Q8
Placenta Previa
Checking Initial Appropriateness 
11/20/2025
CEFUROXIME 1.5GM (VIAL)
11/20/2025
11/21/2025
1.5G
Ivtt
Q8h
SP LTCS
Checking Initial Appropriateness 
11/20/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
PO
500mg
BID
SP LTCS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: